A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes

scientific article published on 7 July 2011

A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BMC.2011.06.039
P932PMC publication ID3193892
P698PubMed publication ID21741845
P5875ResearchGate publication ID51479469

P2093author name stringJason Lee
Ying Wu
Chang-Guo Zhan
Kyung-Bo Kim
Beilei Lei
Na-Ra Lee
Marie Wehenkel
Do-Min Lee
Kimberly Cornish Carmony
P2860cites workImmunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stressQ24296668
Profiling proteasome activity in tissue with fluorescent probesQ33294646
The ubiquitin system, disease, and drug discoveryQ33384295
Immunoproteasomes: regulating the regulatorQ33879127
Beta 2 subunit propeptides influence cooperative proteasome assemblyQ34161423
Antigen processing by the proteasomeQ34193262
Activity-based protein profiling for biochemical pathway discovery in cancerQ34493489
A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivoQ34582794
Immunoproteasomes and immunosenescenceQ35548615
Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteinsQ35794032
Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discoveryQ36009873
Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunitsQ36381008
Tagging and detection strategies for activity-based proteomics.Q36686285
Activity-based protein profiling: from enzyme chemistry to proteomic chemistryQ37119021
Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitorsQ37187543
Chemical biology approaches to probe the proteome.Q37313174
Catalytic mechanism and assembly of the proteasome.Q37407654
Design, synthesis and biological application of chemical probes for bio-imagingQ37725669
LMP2-specific inhibitors: chemical genetic tools for proteasome biologyQ40140606
Chemical proteomics profiling of proteasome activityQ40265383
Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cellsQ40377778
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomibQ40431708
Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomesQ40658264
Association of immunoproteasomes with the endoplasmic reticulumQ40839103
Intracellular distribution of proteasomesQ41729840
Dynamic imaging of protease activity with fluorescently quenched activity-based probes.Q42806191
Mechanisms underlying nonsteroidal anti-inflammatory drug-induced p27(Kip1) expressionQ44219313
Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes.Q46006433
Proteomics evaluation of chemically cleavable activity-based probesQ46087149
Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brainsQ46812261
Acetylene functionalized BODIPY dyes and their application in the synthesis of activity based proteasome probesQ46987117
Proteasomes in immune cells: more than peptide producers?Q53354360
Enhanced intestinal expression of the proteasome subunit low molecular mass polypeptide 2 in patients with inflammatory bowel diseaseQ79424147
Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout miceQ80194141
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectimmunoproteasomeQ106087471
P304page(s)607-613
P577publication date2011-07-07
P1433published inBioorganic & Medicinal ChemistryQ2904200
P1476titleA bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes
P478volume20

Reverse relations

cites work (P2860)
Q37502160A FRET-based approach for identification of proteasome catalytic subunit composition
Q37136304Activity-based imaging probes of the proteasome
Q36201624Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells
Q39096761Activity-based probes for the multicatalytic proteasome
Q35825193Cell permeable affinity- and activity-based probes
Q35555565Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes
Q38837519Emerging role of immunoproteasomes in pathophysiology
Q37292307Inhibitors of the immunoproteasome: current status and future directions
Q38192572Peptide-based proteasome inhibitors in anticancer drug design.

Search more.